Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

NCT05166967 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Haploidentical Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Individual Antithymocyte globulin
DRUG: Antithymocyte globulin

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]
[object Object]